Decreased expression of Sirt1 contributes to ocular Behcet’s disease progression via Th17 and Th22 response
Ophthalmic Research Nov 10, 2020
Xie M, et al. - Researchers conducted the study for analyzing the role of Sirtuin 1 (Sirt1) in the pathogenesis of ocular Behcet’s disease (OBD). Using enzyme-linked immunosorbent assay (ELISA), Sirt1 and cytokine levels were measured. The frequencies of Th17 and Th22 cells have been detected using flow cytometry. Decreased expression of Sirt1 was observed in CD4 + T cells obtained from active OBD patients. The findings indicate that decreased expression of Sirt1 may be involved in OBD pathogenesis and that Sirt1 activation may be considered a potential target for OBD.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries